Thyroid Cancer Diagnostics: Industry Analysis, Size, Share, Growth, Trends and Forecast
Author : Ganesh patil | Published On : 28 Mar 2024
Discover a detailed exploration of the Thyroid Cancer Diagnostics Market by Data Bridge Market Research, thoughtfully presented with visual finesse to ensure seamless data absorption. Crucial insights are illuminated through vivid graphs, charts, and figures, empowering astute decision-making.
This Thyroid Cancer Diagnostics report defines and segments the market with analyzes and projections of the market size in terms of value, volume and technology. The Thyroid Cancer Diagnostics research report also identifies driving and restraining factors of the global market with an analysis of the trends, opportunities and challenges. This Thyroid Cancer Diagnostics report examines the leading manufacturers of the market with sales, revenue and price. The facts and data of the market are represented in this report using diagrams, graphs, pie charts and other pictorial representations.
This Thyroid Cancer Diagnostics report firstly introduced basic information which includes definition, classification, application, Industry chain structure and Industry view. To ensure the quality of the report further, market dynamics, various projection, demographic changes, historic details and other have been included in this Thyroid Cancer Diagnostics report. Analysts have studied the investments in research and development of products and technologies that are expected to give the players a definite boost.
Data Bridge Market Research analyses that the market is growing with a CAGR of 5.7% in the forecast period of 2023 to 2030 and is expected to reach USD 11,063.67 million by 2030.
Get Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-thyroid-cancer-diagnostics-market
Market Growth Drivers:
RISING INCIDENCE AND PREVALENCE OF THYROID NODULES & CANCER
A thyroid nodule is an unusual growth (lump) of thyroid cells in the thyroid gland. Sometimes the normal thyroid soft tissue started to grow, causing these nodules to form. Nodule incidence increases with age and mainly in women, mainly in those with iodine deficiency and after radiation exposure. Although the further complication of these nodules is thyroid cancer, the chances of converting thyroid nodules to thyroid cancer are low. According to an article published in NCBI named "Risk of Malignancy in Thyroid Nodules 4 cm or Larger" in 2017, cancer occurrence after nodules is found in less than 5% of the total nodules cases. Moreover, the thyroid nodules run in the family history and in people whose iodine intake is low.
RISING THYROID CANCER DIAGNOSTIC TESTS
Thyroid ultrasound is a sound wave picture of the thyroid gland taken by a hand-held instrument and translated to a 2-dimensional picture on a monitor. It is used in the diagnosis of tumors, cysts, or goiters of the thyroid and is a painless, no-risk procedure. These tests are used to evaluate structural anomalies, whereas blood tests measuring TSH, T4, and T3 levels are used to examine functional variables. Fine needle biopsy is used in suspicious cases to determine whether a tumor is benign or malignant. Furthermore, the introduction of molecular testing and the genetic prognosis fuel the diagnostic landscape in this market for thyroid cancer diagnostics.
RISING AWARENESS TOWARDS THYROID CANCER
Growing thyroid cancer awareness has led to an increased demand for timely cancer detection, leading to market growth.
Thyroid cancer is one of the major causes of rising mortality rates among U.S. populations worldwide, fueling the market growth over the next five years. Exposure to radiation and a family history of thyroid issues are major risk factors for thyroid cancer. Women are diagnosed with thyroid cancer significantly more than men.
Notably, the report emphasizes the engagement of essential entities, including:
Canon Inc., FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Illumina, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Abbott, General Electric Company, BD, QIAGEN, DIASORIN S.P.A., Merck KGaA, Hologic, Myriad Genetics Inc., BIOMERIEUX, FONAR Corp., Time Medical Holding., PlexBio., MinFound Medical Systems Co., Ltd, Medonica Co. LTD, Beijing O&D Biotech Co., Ltd., and SternMed GmbH. among others
Navigating Market Realities: Essential Points Uncovered
- Holistic Market Share Appraisals
- Comprehensive evaluation of market shares at both global and regional levels.
- Parent Market Potential & Growth in Niche Areas
- Insightful exploration of parent market potential and identification of niche segments poised for growth.
- Deciphering Order Management Software Market Trends
- In-depth analysis of global order management software trends, offering insights for strategic investments.
- Adapting to Evolving Industry Dynamics
- Navigate and adapt to the dynamic shifts within the industry landscape.
- Strategies of Key Players & Product Landscape
- Uncover the strategies employed by key players and explore their diverse product landscapes.
- Historical & Future Market Size Assessment
- Comprehensive evaluation of historical, current, and projected market sizes.
- Strategic Profiling: Key Player Insights
- Strategic profiling of key players, providing detailed insights into market positions and core competencies.
Key Market Segmentation
By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Biopsy, Blood Test, Others), Cancer Type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (Below 21, 21-29, 30-65, 65 and Above), End User (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales)
Intended Audience:
- Companies within the Thyroid Cancer Diagnosticsindustry
- Investors and analysts keen on the Thyroid Cancer Diagnosticsmarket
- Individuals seeking insights into the dynamics of the Thyroid Cancer Diagnosticsmarket
Read More About This Market Intelligence Report @ https://www.databridgemarketresearch.com/reports/global-thyroid-cancer-diagnostics-market
Discover More Insightful Reports:
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research operates as a multinational management-consulting firm, boasting offices situated in both India and Canada. Renowned for our innovative and cutting-edge market analysis methodologies, we pride ourselves on our unparalleled durability and forward-thinking approaches. Our commitment lies in unravelling optimal consumer prospects and nurturing invaluable insights to empower your company's success within the market.
With a team comprising over 500 analysts specializing in various industries, we have been instrumental in serving over 40% of Fortune 500 companies on a global scale. Our extensive network boasts a clientele exceeding 5000+, spanning across the globe. At Data Bridge Market Research, our goal remains steadfast: to provide comprehensive market intelligence and strategic guidance to propel your business toward success.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com
